Seminar In Investigative Medicine with Alan Shuldiner, MD


The next Seminar In Investigative Medicine lecture is scheduled for Tuesday, April 5th in the Goldman International Conference Center of the Feinstein Institute for Medical Research. Our guest speaker will be Alan Shuldiner, MD, John A. Whitehurst Professor of Medicine, associate dean for Personalized Medicine, director of the Program in Personalized and Genomic Medicine, and head of the Division of Endocrinology, Diabetes and Nutrition at the University of Maryland School of Medicine; and vice president and co-head of the Regeneron Genetics Center.

Dr. Shuldiner will be presenting, “Taking Genomic Discovery to Patients and Population: DiscovEHR”, and will be hosted by Jesse Roth, MD, FACP.

Goal: The overall goal for the RSC (Regularly Scheduled Conference) is to inform physicians of new developments in understanding basic mechanisms of disease and novel therapeutics that capitalize on a deeper appreciation of disease pathophysiology.

Program Objectives: Upon completion of this session, participants should be able to:

  • Identify new developments in understanding mechanisms of disease.
  • Integrate new investigational results with current diagnostic and treatment protocols.
  • Judge the potential importance for current best practices of treatment regimes based on new translational studies

Target Audience: Researchers, Students, Hospital-based physicians, Housestaff, Nurses, and Community physicians.

CME ACCREDITATION: Northwell Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT: Northwell Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Each physician should only claim credit commensurate with the extent of their participation in the activity.

DISCLOSURE POLICY: Northwell Health adheres to the ACCME’s New Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners and managers, are required to disclose all financial relationships with commercial interests. All identified potential conflicts of interest are thoroughly vetted by Northwell Health for fair balance and scientific objectivity and to ensure appropriateness of patient care recommendations.

Planner and Speaker’s Disclosures:
Bettie Steinberg, PhD, RSS planner, has no financial relationship to disclose. Alan Shuldiner, MD, guest speaker, receives salary from Regeneron Genetics Center/Regeneron Pharmaceutical, Inc. for being a full time employee.

Recognition of Program Support: An announcement of program support will be made to all attendees at the beginning of each Regularly Scheduled Session.

Alan Shuldiner, MD
350 Community Drive
Goldman Conference Room
Manhasset, NY 11030